Placeholder

Pseudoephedrine Hydrochloride

  • # LGM Pharma is a Pseudoephedrine Hydrochloride CAS# 345-78-8 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Pseudoephedrine Hydrochloride
  • CAS #: 345-78-8
  • IUPAC: Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, hydrochloride (1:1), (alphaS)-
  • Formula: C10-H15-N-O.Cl-H
  • Synonyms: (+)-Pseudoephedrine hydrochloride , 1S,2S-(+)-Pseudoephedrine hydrochloride , Benzenemethanol, alpha-(1-(methylamino)ethyl)-, (S-(R*,R*))-, , hydrochloride , Benzenemethanol, alpha-(1-(methylamino)ethyl)-, , hydrochloride, (S-(R*,R*))- , Besan , CoAdvil , CPDD 0050 , D-(alpha-(1-Methylamino)ethyl)benzyl alcohol hydrochloride , d-(alpha-(1-Methylamino)ethyl)benzyl alcohol hydrochloride , D-Pseudoephedrine hydrochloride , d-Pseudoephedrine hydrochloride , EINECS 206-462-1 , First sign , L(+)-Pseudoephedrine hydrochloride , Novafed , NSC 106567 , NSC 33634 , Otrinol , PediaCare Decongestant Drops , Pseudoephedrine HCl , Pseudoephedrine hydrochloride , Pseudophedrine hydrochloride , Rhinalair , Sinufed , Sudafed , Sudafed 12 Hour , Sudafed 24 Hour , Sudafed hydrochloride , Sudafed Liquid, Children's , Sudomyl , Sun mark sinus , Suphedrine , Symptom 2 , Topcare 12 hour decongestant , Tussaphed , UNII-6V9V2RYJ8N
  • SMILES: Cl.[C@H](O)(c1ccccc1)[C@@H](NC)C
  • InChl: InChI=1S/C10H15NO.ClH/c1-8(11-2)10(12)9-6-4-3-5-7-9;/h3-8,10-12H,1-2H3;1H/t8-,10+;/m0./s1
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants

 

  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service